{"id":"https://genegraph.clinicalgenome.org/r/5709aadd-23f2-4579-9a38-387ec9cec361v1.1","type":"EvidenceStrengthAssertion","dc:description":"Variants in *CACNA2D4* were first associated with autosomal recessive inheritance of retinal cone dystrophy (RCD4) in 2006 (Wycisk et al., 17033974). Over eight probands reported four homozygous variants in this gene including one missense variant, and two large deletions covering multiple exons, as well as one stop gained.\n\nThis gene-disease association is supported by expression throughout the inner nuclear layer of the retina, photoreceptors and retinal periphery in model organism, zebrafish by RNA *in situ* hybridization (Schlegel et al., 31834350). Additional functional studies show alterations in *Cacna2d4* in mice have significantly reduced transcript levels in the retina leading to structural and functional abnormalities of retinal ribbon synapses including substantial loss of photoreceptor activities and photoreceptor cell death (Wycisk et al., 16877424). More evidence is available in the literature, but the maximum score for genetic evidence and experimental evidence (12.0 pts.) has been reached.\n\nIn summary, *CACNA2D4* is definitively associated with autosomal recessive inheritance of CACNA2D4-related retinopathy, and this has been has been upheld over time. This classification has been approved by the ClinGen Retina GCEP on March 2nd, 2023 (SOP Version 9).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/5709aadd-23f2-4579-9a38-387ec9cec361","GCISnapshot":"https://genegraph.clinicalgenome.org/r/f413ef18-b8cf-44c3-abde-b7533e1dd54f","calculatedEvidenceStrength":"Definitive","changes":{"id":"cg:summaryChange"},"contributions":[{"id":"https://genegraph.clinicalgenome.org/r/f413ef18-b8cf-44c3-abde-b7533e1dd54f_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10072","date":"2024-06-29T03:42:02.864Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/f413ef18-b8cf-44c3-abde-b7533e1dd54f_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10072","date":"2023-03-02T17:00:00.000Z","role":"Approver"}],"curationReasons":["DiseaseNameUpdate"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f413ef18-b8cf-44c3-abde-b7533e1dd54f_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f413ef18-b8cf-44c3-abde-b7533e1dd54f_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/24486631-1c5c-484f-bbfd-d89267cdddd0","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1be76a10-4de7-4f21-bae6-861b53880ad8","type":"Finding","dc:description":"In situ hybridization of zebrafish cacna2d4a and cacna2d4b in 3 dpf zebrafish, cacna2d4a is expressed throughout the retinal INL and in photoreceptors (Phs) of the retinal periphery and in the retinal INL and distal photoreceptors in adults, while cacna2d4b shows weak expression in INL in larval Zebrafish.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31834350","rdfs:label":"In situ hybridization of Zebrafish cacna2d4a and cacna2d4b ","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/f413ef18-b8cf-44c3-abde-b7533e1dd54f_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cd80cc95-8f95-4b87-ab8f-b3b7cfa27d3d","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9fb3de5f-8e7e-4172-9382-967003cc3514","type":"Finding","dc:description":"Since a2d subunits are known to set the abundance of Cav1 channels the localization of Cacna1fa, the pore-forming subunit of Cav1.4 in photoreceptors was investigated in wild type and KO\nanimals at different developmental stages. cacna2d4a-KO did not lead to changes in expression of Cacna1fa; however, cacna2d4b-KO not only reduced the abundance of Cacna1fa at the photoreceptor terminals, but also led to the appearance of Cacna1fa puncta more distal of\nthe plexiform layer. This lowered expression of cacna1f at the ribbon synapses is predicted to lead to impaired signal transmission which mimics decreased cone response in ERG.\ncacna2d4a did not lead to changes in expression of Cacna1fa\nat 5 dpf; however, lack of cacna2d4b not only reduced the\nabundance of Cacna1fa at the photoreceptor terminals, but\nalso led to the appearance of Cacna1fa puncta more distal of\nthe plexiform layer (arrows). This phenotype was also found in\nolder larvae (20 dpf).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31834350","rdfs:label":"Cacna1fa localization cacna2d4-KO lines","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/64b362be-f519-41a2-84c0-a0bbdb0b384c","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fc3320df-0e13-4b92-9aa5-51b5ccb68db6","type":"Finding","dc:description":"CACNA2D4 is necessary for the proper assembly of the channel subunits and loss of CACNA2D4 results in lower expression of channel subunit CACNA1F resulting in diminished synaptic transmission measured by cone response using ERG.  Double-KO at 5 dpf exhibited a significantly decreased b-wave amplitude from dim to bright light stimuli and slower b-wave kinetics both indicative of impaired signal transmission. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31834350","rdfs:label":"Cacna1fa localization cacna2d4-KO lines","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":4.5},{"id":"https://genegraph.clinicalgenome.org/r/f413ef18-b8cf-44c3-abde-b7533e1dd54f_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ad1c4155-1a89-46b7-ae47-da2ed6f8f183_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ad1c4155-1a89-46b7-ae47-da2ed6f8f183","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17033974","rdfs:label":"II-1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":33,"allele":{"id":"https://genegraph.clinicalgenome.org/r/2bb30d6f-2aa0-4060-9e54-0cc79b4df9f1","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_172364.5(CACNA2D4):c.2406C>A (p.Tyr802Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA115580"}},"detectionMethod":"Mutational analysis was performed by Sanger sequencing in the candidate gene. ","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Sanger sequencing","phenotypes":["obo:HP_0030469","obo:HP_0000548","obo:HP_0000007","obo:HP_0007663","obo:HP_0000551","obo:HP_0001133"],"previousTesting":false,"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/e67282f3-904f-40a2-a493-c5cb6fbc37f6_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17033974","allele":{"id":"https://genegraph.clinicalgenome.org/r/2bb30d6f-2aa0-4060-9e54-0cc79b4df9f1"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/e67282f3-904f-40a2-a493-c5cb6fbc37f6","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e67282f3-904f-40a2-a493-c5cb6fbc37f6_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/2f341a0d-2368-4b97-a48d-d7a26fcb2573_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2f341a0d-2368-4b97-a48d-d7a26fcb2573","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25356976","rdfs:label":"W58-1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":42,"allele":{"id":"https://genegraph.clinicalgenome.org/r/79eb275d-74a5-4e29-911f-b87e48320245","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_172364.5(CACNA2D4):c.2120G>A (p.Arg707His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA6386841"}},"detectionMethod":"The authors of the study developed a panel for targeted DNA capture and sequencing by selecting 164 known IRD-related genes from RetNet and OMIM, 88 possible candidate genes and 32 abundant retinal miRNAs. Mutations were validated using Sanger sequencing. ","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Next generation sequencing panels","phenotypes":["obo:HP_0000007","obo:HP_0000548","obo:HP_0000505","obo:HP_0007663"],"previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/e651964e-96e3-442c-94a6-ea83210ba2bb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25356976","allele":{"id":"https://genegraph.clinicalgenome.org/r/79eb275d-74a5-4e29-911f-b87e48320245"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/e651964e-96e3-442c-94a6-ea83210ba2bb","type":"EvidenceLine","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e651964e-96e3-442c-94a6-ea83210ba2bb_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/f1b9801f-0452-4d54-aa12-1cce8933ef52_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f1b9801f-0452-4d54-aa12-1cce8933ef52","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26560832","rdfs:label":"Proband 2","ageType":"AgeAtReport","ageUnit":"Years","ageValue":41,"allele":{"id":"https://genegraph.clinicalgenome.org/r/503e5ca8-8892-4886-a63f-c7d25bcbc1f5","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_172364.4(CACNA2D4):c.1720-74_2551+1189delinsTG","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/375308"}},"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Whole genome shotgun sequencing","phenotypes":"obo:HP_0000512","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/ddb7b6f0-523d-4448-ac55-86beae8ce48d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26560832","allele":{"id":"https://genegraph.clinicalgenome.org/r/503e5ca8-8892-4886-a63f-c7d25bcbc1f5"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/ddb7b6f0-523d-4448-ac55-86beae8ce48d","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ddb7b6f0-523d-4448-ac55-86beae8ce48d_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/f413ef18-b8cf-44c3-abde-b7533e1dd54f_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4fe435fa-1d25-4bf2-8cc9-d47c856165ac_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17033974","rdfs:label":"family of patient II-1","estimatedLodScore":0.98,"family":{"id":"https://genegraph.clinicalgenome.org/r/4fe435fa-1d25-4bf2-8cc9-d47c856165ac","type":"Family","rdfs:label":"family of patient II-1","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/ad1c4155-1a89-46b7-ae47-da2ed6f8f183"}},"meetsInclusionCriteria":true,"phenotypeNegativeAlleleNegative":3,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0000007","obo:HP_0001133","obo:HP_0007663","obo:HP_0000548","obo:HP_0000551","obo:HP_0030469"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/ad1c4155-1a89-46b7-ae47-da2ed6f8f183"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/b7fb6f1a-f037-40ab-941c-888ff3ed2b05_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b7fb6f1a-f037-40ab-941c-888ff3ed2b05","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26560832","rdfs:label":"Proband 1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":22,"allele":{"id":"https://genegraph.clinicalgenome.org/r/a98c7a61-350e-4e08-9c05-6545361a4fdf","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_172364.5(CACNA2D4):c.1882C>T (p.Arg628Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA204549"}},"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Whole genome shotgun sequencing","phenotypes":["obo:HP_0000548","obo:HP_0000551","obo:HP_0000613","obo:HP_0000512","obo:HP_0007663","obo:HP_0500041","obo:HP_0000007"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/53adb643-b9ed-495b-93a7-1da400f5c85d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26560832","allele":{"id":"https://genegraph.clinicalgenome.org/r/a98c7a61-350e-4e08-9c05-6545361a4fdf"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/53adb643-b9ed-495b-93a7-1da400f5c85d","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/53adb643-b9ed-495b-93a7-1da400f5c85d_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/40329375-c051-433d-9bd4-84bff4d2cf69_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/40329375-c051-433d-9bd4-84bff4d2cf69","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28041643","rdfs:label":"W000244","allele":{"id":"https://genegraph.clinicalgenome.org/r/a98c7a61-350e-4e08-9c05-6545361a4fdf"},"detectionMethod":"A subset of the pathogenic SNVs and indels was confirmed by Sanger sequencing. Genotyping using HumanCoreExome-24 v.1.0 BeadChip (Illumina) was also performed, followed by SV identification using GenomeStudio and cnvPartition software (Illumina).","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Whole genome shotgun sequencing","previousTesting":true,"previousTestingDescription":"The majority of subjects had some type of previous testing including single-gene Sanger sequencing or targeted gene panel sequencing, however 152 subjects had no prior testing.","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/b169c48d-ff5d-4953-ace7-7cc1408fc866_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28041643","allele":{"id":"https://genegraph.clinicalgenome.org/r/a98c7a61-350e-4e08-9c05-6545361a4fdf"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/b169c48d-ff5d-4953-ace7-7cc1408fc866","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b169c48d-ff5d-4953-ace7-7cc1408fc866_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":8589,"specifiedBy":"GeneValidityCriteria9","strengthScore":16.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/4x_JLDxN7xo","type":"GeneValidityProposition","disease":"obo:MONDO_0700244","gene":"hgnc:20202","modeOfInheritance":"obo:HP_0000007"},"version":"1.1","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_f413ef18-b8cf-44c3-abde-b7533e1dd54f-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}